Skip to main content
. 2018 Apr 27;9(32):22480–22497. doi: 10.18632/oncotarget.25132

Figure 14. Antitumor activity of 47-mG2a and 47-mG2a-f against HSC-2 xenografts (500 μg/day; 25 mg/kg).

Figure 14

(A) Comparison of tumor size (day 15). (B) Tumor weight of HSC-2 xenografts (day 15). An asterisk indicates statistical significance (**P < 0.01, Tukey-Kramer's test).